Why the study?
Does early levosimendan infusion in the operating theatre improve clinical outcomes compared to delayed infusion in the ICU in patients with compromised cardiac function undergoing open-heart surgery?
Population
45 consecutive patients with compromised cardiac function undergoing open-heart surgery
Comparison
Levosimendan infusion starting in the operating… vs Levosimendan infusion starting in the ICU when…
Design
RCT, Randomised
Follow-up
Until hospital discharge
Authors
Loading...
Early levosimendan in the operating theatre shortens ICU and hospital stays; extends evidence on optimal timing in compromised cardiac function.
Does early levosimendan infusion in the operating theatre improve clinical outcomes compared to delayed infusion in the ICU in patients with compromised cardiac function undergoing open-heart surgery?
Starting levosimendan infusion early in the operating theatre rather than waiting until the ICU significantly reduces ICU and hospital length of stay in patients with compromised cardiac function undergoing open-heart surgery.
Tasouli et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: